Abstract:Objectives: Integrins, the coordinator of extracellular and intracellular signaling, are often found to be aberrant in tumors and can reshape the tumor microenvironment. Although previous studies showed that integrin beta 2 (ITGB2) is important for host defense, its expression profile and role in tumors, especially in cancer associated fibroblasts (CAFs) are still unknown. Methods: Immunofluorescence stain and fluorescence activated cell sorting were used to analyze the ITGB2 expression profile in oral squamous cell carcinoma (OSCC). RT-PCR and western blot were used to compare ITGB2 expression in normal fibroblasts (NFs) and cancer associated fibroblasts (CAFs). Clinical data and function-based experiments were used to investigate the promoting tumor growth ability of ITGB2 expressing CAFs. Enhanced glycolysis activity was identified by using bioinformatics analyses and GC/MS assays. MCT1 knockdown OSCC cell lines were constructed to explore the pro-proliferative mechanisms of ITGB2 expressing CAFs in multiple in vitro and in vivo assays. Results: We found that CAFs exhibited significantly higher ITGB2 expression than the matched NFs. In addition, higher ITGB2 expression in CAFs was correlated with higher TNM stages and more Ki67+ tumor cells, indicating its ability to promote OSCC proliferation. Further, co-culture assay demonstrated that ITGB2-mediated lactate release in CAFs promoted OSCC cell proliferation. Mechanically, ITGB2 regulated PI3K/AKT/mTOR pathways to enhance glycolysis activity in CAFs. Accordingly, lactate derived from ITGB2-expressing CAFs was absorbed and metabolized in OSCC to generate NADH, which was then oxidized in the mitochondrial oxidative phosphorylation system (OXPHOS) to produce ATP. Notably, inhibiting the OXPHOS system with metformin delayed the proliferative capacity of OSCC cells cultured in the ITGB2-expressing CAFs medium. Conclusions: Our study uncovered the ITGB2high pro-tumoral CAFs that activated the PI3K/AKT/mTOR axis to promote tumor proliferation in OSCC by NADH oxidation in the mitochondrial oxidative phosphorylation system.

PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy

TGF-βRII Regulates Glucose Metabolism in Oral Cancer-Associated Fibroblasts Via Promoting PKM2 Nuclear Translocation.

Glycometabolic Reprogramming-Mediated Proangiogenic Phenotype Enhancement of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: Role of PGC-1α/PFKFB3 Axis.

TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer

Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway

Tumoral Microvesicle–activated Glycometabolic Reprogramming in Fibroblasts Promotes the Progression of Oral Squamous Cell Carcinoma

HIF1A-dependent Overexpression of MTFP1 Promotes Lung Squamous Cell Carcinoma Development by Activating the Glycolysis Pathway

Metabolic Reprogramming of Cancer-Associated Fibroblasts by Idh3 Alpha Downregulation

ITGB2-mediated Metabolic Switch in CAFs Promotes OSCC Proliferation by Oxidation of NADH in Mitochondrial Oxidative Phosphorylation System

Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression

Autophagy is Involved in TGF-β1-induced Protective Mechanisms and Formation of Cancer-Associated Fibroblasts Phenotype in Tumor Microenvironment.

Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis

Stromal-epithelial Lactate Shuttle Induced by Tumor‑derived Interleukin‑1β Promotes Cell Proliferation in Oral Squamous Cell Carcinoma.

MiR-3529-3p from PDGF-BB-induced cancer-associated fibroblast-derived exosomes promotes the malignancy of oral squamous cell carcinoma

Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer

Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma Via the PDGF-BB/PDGFR-β Mediated Paracrine Signaling Network.

Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation.

Cancer-cell-secreted Exosomal Mir-105 Promotes Tumour Growth Through the MYC-dependent Metabolic Reprogramming of Stromal Cells

Glycolysis Promotes MDSCs and Cancer Stemness Through the Interaction Between Sirt1 and C/EBPb

Paracrine Signaling by Platelet-Derived Growth Factor-Cc Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts

c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3